{
  "version": "1.2.0",
  "chapters": [
    {
      "title": "Review of recent performance of sector\r",
      "startTime": 61,
      "endTime": 179.99
    },
    {
      "title": "Fabian’s current take on biotech\r",
      "startTime": 179.99,
      "endTime": 211.99
    },
    {
      "title": "Are fundamentals for biotech intact?\r",
      "startTime": 211.99,
      "endTime": 359.99
    },
    {
      "title": "Clinical trials that could yield interesting results\r",
      "startTime": 359.99,
      "endTime": 457.99
    },
    {
      "title": "Opinions on the mRNA-based therapies\r",
      "startTime": 457.99,
      "endTime": 551.99
    },
    {
      "title": "M&A in the biotech sector",
      "startTime": 551.99,
      "endTime": 701.81
    }
  ]
}